Literature DB >> 9747221

[Muscular damage during isotretinoin treatment].

A M Heudes1, L Laroche.   

Abstract

BACKGROUND: The effect of isotretinoin on muscle is considered to be uncommon and benign. We analyzed the files of all our patients given isotretinoin over a 5-year period and determined the incidence and gravity of its effect on muscles.
MATERIALS AND METHODS: Sixty treatments with isotretinoin were studied. Myalgia and elevated CPK observed at the pretherapeutic consultation and each month or 2 months thereafter were recorded.
RESULTS: Muscle symptoms were noted in 60 p. 100 of the cases: myalgia in 51 p. 100 and elevated CPK in 41 p. 100. In this group, male sex (H/F = 2.6) and sports activities (70 p. 100) were found more often. In 5 patients, CPK level was 5 times the normal, defining rhabdomyolysis. One patient interrupted treatment because of persistently high CPK levels. DISCUSSION: Myalgia and elevated CPK signal skeletal muscle involvement. These signs were more frequent in our series than in reports in the literature, probably because we systematically looked for them. Besides use of isotretinoin, one case of viral infection and sports activities, no other explanatory cause could be found. Isotretinoin could have a potentializing effect on other myotoxicity inducers (drugs, infection, fever, muscular exertion...). The benign nature of the muscle effect appears to be validated although there were some patients who had persistent and/or severe signs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747221

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  9 in total

1.  Isotretinoin and FoxO1: A scientific hypothesis.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2011-07-01

2.  Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin.

Authors:  Benno Hartung; Hans F Merk; Wolfgang Huckenbeck; Thomas Daldrup; Eva Neuen-Jacob; Stefanie Ritz-Timme
Journal:  Int J Legal Med       Date:  2012-08-16       Impact factor: 2.686

Review 3.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

4.  Isotretinoin-induced acute severe myopathy involving pelvic girdle muscles: A case report.

Authors:  Farah Sameem
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

5.  Presumed isotretinoin-induced extraocular myopathy.

Authors:  Md Shahid Alam; Swati Agarwal
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec

6.  Effect of oral isotretinoin on muscle strength in patients with acne vulgaris: a prospective controlled study.

Authors:  Cevriye Mülkoğlu; Nermin Karaosmanoğlu
Journal:  BMC Pharmacol Toxicol       Date:  2021-03-20       Impact factor: 2.483

7.  Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study.

Authors:  Emine Müge Acar; Senem Şaş; Fatmanur Aybala Koçak
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

8.  Myositis Induced by Isotretinoin: A Case Report and Literature Review.

Authors:  Julián Alejandro Rivillas; Víctor Alfonso Santos Andrade; Andrés Alberto Hormaza-Jaramillo
Journal:  Am J Case Rep       Date:  2020-01-20

9.  A Common Drug With a Dangerous Side Effect: Acute Rhabdomyolysis Caused by the Synergistic Effect of Isotretinoin and Exercise in an Adolescent.

Authors:  Kingshuk Dasgupta; Peter Lim; Hannah Reedstorm
Journal:  Cureus       Date:  2020-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.